Anebulo Pharmaceuticals, Inc. — Form D

Anebulo Pharmaceuticals, Inc. of LAKEWAY, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-31. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Jason R AryehDirectorLakeway, TX
Nathaniel R CallowayDirectorLakeway, TX
Richard CunninghamDirectorLakeway, TX
Aron R EnglishDirectorLakeway, TX
Areta R KupchykDirectorLakeway, TX
Joseph F LawlerDirectorLakeway, TX
Kenneth R LinDirectorLakeway, TX
Bimal R ShahDirectorLakeway, TX
Richard CunninghamExecutive OfficerLakeway, TX
Daniel GeorgeExecutive OfficerLakeway, TX
Joseph F LawlerExecutive OfficerLakeway, TX
Simon AllenDirectorLakeway, TX
Simon AllenExecutive OfficerLakeway, TX
Karah R ParschauerDirectorLakeway, TX
Kenneth C CundyExecutive OfficerLakeway, TX
Aron F EnglishDirectorLakeway, TX
James R MerchantExecutive OfficerSalt Lake City, UT

Other filings by this issuer (2)

FiledFormOfferingSold
2022-10-11D$16.2M$6.6M
2020-06-25D$5.3M$3.0M

More